Related Experiment Video
Updated: Jul 25, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
Methotrexate for CSPs
Laure Noël1, Frédéric Chantraine1
1Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire de Liège, Citadelle Hospital, 4000 Liège, Belgium.
Summary
Cesarean scar pregnancies (CSPs) pose risks, prompting termination recommendations. Methotrexate (MTX) offers a potential medical treatment, but optimal administration and efficacy require further research for improved maternal and reproductive outcomes.
Area of Science:
- Reproductive Medicine
- Gynecologic Surgery
- Maternal-Fetal Medicine
Background:
- Cesarean scar pregnancy (CSP) carries significant risks of maternal morbidity.
- Immediate termination is generally advised, but optimal management strategies lack consensus.
- Methotrexate (MTX), a folic acid antagonist, is a potential medical treatment option.
Purpose of the Study:
- To review current knowledge on MTX for CSP termination.
- To discuss MTX administration routes, efficacy, safety, and fertility preservation.
- To compare MTX with alternative treatments and identify prognostic factors for success.
Main Methods:
- Systematic review of existing literature on MTX for CSP.
- Analysis of studies comparing systemic vs. local MTX administration.
- Evaluation of comparative effectiveness and safety data against other modalities.
Main Results:
- Expectant management of CSP is linked to severe maternal morbidity.
- MTX is explored as a non-invasive option, with ongoing debate on optimal administration.
- Evidence on MTX efficacy, safety, and fertility preservation in CSP is still evolving.
Conclusions:
- Optimal management of CSP requires further research, particularly regarding MTX.
- MTX administration route and prognostic factors influence treatment success.
- Evidence-based guidelines are needed to standardize CSP management and optimize outcomes.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
201
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
201
01:26Psychosis: Goals of Pharmacotherapy
171
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
171
01:29Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
158
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
158
01:28Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
01:17Phase II Reactions: Methylation Reactions
240
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
240